Gemcitabine for Injection, USP, 2 g*/vial, Lyophilized powder in a Single-Use Vi Supply Disruption — Mylan Institutional LLC (High
Gemcitabine for Injection, USP, 2 g*/vial, Lyophilized powder in a Single-Use Vi Supply Disruption — Mylan Institutional LLC (High is one of 9,000 drug supply records in the DrugSupply dataset. Key details — Drug name: Gemcitabine for Injection, USP, 2 g*/vial, Lyophilized powder in a Single-Use Vi; Manufacturer: Mylan
| Drug name | Gemcitabine for Injection, USP, 2 g*/vial, Lyophilized powder in a Single-Use Vi |
|---|---|
| Manufacturer | Mylan Institutional LLC |
| Recall/Disruption reason | Presence of Particulate Matter |
| Risk classification | High Risk — Serious Health Hazard |
| Status | Terminated |
| Record type | Enforcement/Recall |
| Recall number | D-1333-2015 |
| Initiation date | 20150323 |
| Quantity affected | 2,455 vials |
| Dosage form | Drugs |
🔍 Search all drug supply records →
$1199/mo
Try DrugSupply →